CA2026030A1 - Compose de maltodextrine/demoussage - Google Patents

Compose de maltodextrine/demoussage

Info

Publication number
CA2026030A1
CA2026030A1 CA2026030A CA2026030A CA2026030A1 CA 2026030 A1 CA2026030 A1 CA 2026030A1 CA 2026030 A CA2026030 A CA 2026030A CA 2026030 A CA2026030 A CA 2026030A CA 2026030 A1 CA2026030 A1 CA 2026030A1
Authority
CA
Canada
Prior art keywords
defoaming
combinate
maltodextrin
weight percent
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2026030A
Other languages
English (en)
Other versions
CA2026030C (fr
Inventor
William Valentine
William K. Valentine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Technology Pharmaceuticals Corp
Original Assignee
Valentine Enterprises Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valentine Enterprises Inc filed Critical Valentine Enterprises Inc
Publication of CA2026030A1 publication Critical patent/CA2026030A1/fr
Application granted granted Critical
Publication of CA2026030C publication Critical patent/CA2026030C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • B01D19/0404—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Degasification And Air Bubble Elimination (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
CA002026030A 1989-10-19 1990-09-24 Compose de maltodextrine/demoussage Expired - Fee Related CA2026030C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/423,877 US5073384A (en) 1989-10-19 1989-10-19 Maltodextrin/defoaming composition combinate
US423,877 1989-10-19

Publications (2)

Publication Number Publication Date
CA2026030A1 true CA2026030A1 (fr) 1991-04-20
CA2026030C CA2026030C (fr) 1997-04-01

Family

ID=23680536

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002026030A Expired - Fee Related CA2026030C (fr) 1989-10-19 1990-09-24 Compose de maltodextrine/demoussage

Country Status (6)

Country Link
US (1) US5073384A (fr)
EP (1) EP0425450B1 (fr)
JP (1) JPH0815521B2 (fr)
AT (1) ATE125170T1 (fr)
CA (1) CA2026030C (fr)
DE (1) DE69021007T2 (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
DE4140116A1 (de) * 1991-12-05 1993-06-09 Bolder Arzneimittel Gmbh Dimeticon-pastillen
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
FR2705966B1 (fr) * 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
CA2128820A1 (fr) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Forme pharmaceutique a desintegration rapide et methode de preparation
EP0731956A4 (fr) * 1993-11-30 1997-04-23 Arch Dev Corp Procede et systeme automatises destines a l'alignement et a la correlation d'images obtenues selon deux techniques d'imagerie differentes
WO1996004128A1 (fr) * 1994-08-03 1996-02-15 Voss Gunter M Procede de fabrication de comprimes enrobes
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
GB9523136D0 (en) * 1995-11-11 1996-01-10 Procter & Gamble Silicone-containing powders
US5908636A (en) * 1996-06-28 1999-06-01 Mcneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
JP3001440B2 (ja) * 1996-11-25 2000-01-24 日本電気通信システム株式会社 仮想ｌａｎ方式
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
MXPA01001969A (es) * 1998-08-25 2002-04-24 Platt Chris Tableta de liberacion temporizada que comprende naproxen y pseudoefedrina.
FR2803720B1 (fr) 2000-01-18 2004-10-22 Roquette Freres Lozenges a base de dextrose et leur procede de fabrication
US6399591B1 (en) 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets
EP1256347A1 (fr) * 2001-05-10 2002-11-13 Swiss Caps Rechte und Lizenzen AG Utilisation de l'amidon pour la préparation d'un agent de traitement thérapeutique
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
WO2004112756A1 (fr) 2003-06-26 2004-12-29 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2648280C (fr) 2006-04-03 2014-03-11 Isa Odidi Dispositif d'administration a liberation commandee comprenant un enrobage organosol
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
JP2011173786A (ja) * 2010-02-23 2011-09-08 Dow Global Technologies Llc セメントスラリーのためのレオロジー調整剤
CN101804199B (zh) * 2010-03-30 2012-07-25 四川健能制药有限公司 一种用于消化道的药物组合物及其应用
GB201014041D0 (en) 2010-08-23 2010-10-06 Biofilm Ltd Soluble film
GB201021170D0 (en) 2010-12-10 2011-01-26 Dow Corning Granulated organopolysiloxane products
EP2649172A1 (fr) 2010-12-10 2013-10-16 Dow Corning Corporation Composition antimousse granulée
JP2013103204A (ja) * 2011-11-16 2013-05-30 Shin-Etsu Chemical Co Ltd 粉末消泡剤及びその製造方法
CN104363897A (zh) 2012-06-12 2015-02-18 宝洁公司 泡腾剂型
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
JP6026859B2 (ja) * 2012-11-16 2016-11-16 楠本化成株式会社 水性塗料用消泡剤の消泡性改良剤
JP5969360B2 (ja) * 2012-11-19 2016-08-17 楠本化成株式会社 揮発分のない水性塗料用消泡剤
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
EP3294269A1 (fr) 2015-06-12 2018-03-21 Santa Farma Ilaç Sanayi A.S. Composition pharmaceutique orale comprenant du bromure d'otilonium et de la siméthicone présentant une certaine densité en vrac et des caractéristiques de dissolution améliorées
MX385008B (es) * 2016-12-14 2025-03-14 Rhein Siegfried Sa De Cv Composicion mejorada de lansoprazol y simeticona y procesos para prepararla.
JP2023533486A (ja) * 2020-07-03 2023-08-03 アーラ フーズ アンバ 中性インスタント飲料ホエイプロテイン粉末
CN112044119A (zh) * 2020-09-07 2020-12-08 安徽銮威化工科技开发有限公司 一种pvc用有机硅消泡剂及其制备方法
CN112263851A (zh) * 2020-09-30 2021-01-26 四川健能制药有限公司 一种二甲硅油消泡组合物的制备方法
CN118251215A (zh) 2021-11-16 2024-06-25 强生消费者公司 含有西甲硅油的可定制剂型

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA508856A (fr) * 1955-01-04 Shell Development Company Detersifs non mousseux
US2441098A (en) * 1946-09-09 1948-05-04 Corning Glass Works Methyl siloxane polymers and method of preparation
US2774710A (en) * 1952-12-15 1956-12-18 Organon Pharmaceutical preparation for the treatment of hyperacidity
NL253992A (fr) * 1959-07-20
US3207698A (en) * 1963-02-13 1965-09-21 Nopco Chem Co Composition and method for defoaming aqueous systems
US3304266A (en) * 1963-05-06 1967-02-14 Dow Corning Foam control agents
US3388073A (en) * 1963-12-16 1968-06-11 Nalco Chemical Co Process of defoaming and inhibiting foam formation in aqueous systems
US3326754A (en) * 1965-06-10 1967-06-20 Rexall Drug Chemical Method of relieving gastrointestinal distress with tributyl phosphate
US3501571A (en) * 1965-12-06 1970-03-17 Smithkline Corp Novel silicone compositions and method of preparing same
US3849194A (en) * 1966-12-19 1974-11-19 Cpc International Inc Low d.e. starch conversion products
USRE30880E (en) * 1967-03-24 1982-03-09 Grain Processing Corporation Low D.E. starch conversion products
US3528929A (en) * 1967-05-24 1970-09-15 Buckman Labor Inc Defoaming,deaerating,and drainage aid compositions
US3663369A (en) * 1968-02-23 1972-05-16 Grain Processing Corp Hydrolysis of starch
DE1914684B2 (de) * 1969-03-22 1975-12-04 Th. Goldschmidt Ag, 4300 Essen Entschäumeremulsion
DE1936126C3 (de) * 1969-07-16 1973-12-06 Bayer Ag, 5090 Leverkusen Entschäumer
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
US3909445A (en) * 1970-03-18 1975-09-30 Mobil Oil Corp Method for reducing foam in water containing systems
US3714068A (en) * 1970-12-28 1973-01-30 Philadelphia Quartz Co Silica
US3705859A (en) * 1970-12-30 1972-12-12 Hercules Inc Method of abating foam formation in aqueous systems
US4298400A (en) * 1971-01-18 1981-11-03 Grain Processing Corporation Low D.E. starch conversion products
GB1378874A (en) * 1971-07-01 1974-12-27 Dow Corning Ltd Foam control substance
US3784479A (en) * 1972-05-15 1974-01-08 Dow Corning Foam control composition
BE788249A (fr) * 1972-05-15 1973-02-28 Dow Corning Compositions de silicones pour lutter contre le moussage dans les procedes de teinture au jet
US4102823A (en) * 1972-12-08 1978-07-25 The Procter & Gamble Company Low and non-phosphate detergent compositions
US4115553A (en) * 1973-12-10 1978-09-19 Armour Pharmaceutical Company Antacid tablets
US3912652A (en) * 1973-12-17 1975-10-14 Dow Corning Defoaming composition useful in jet dyeing
US3959176A (en) * 1974-09-09 1976-05-25 Drew Chemical Corporation Non-foaming dispersing composition
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4230693A (en) * 1975-04-21 1980-10-28 Armour-Dial, Inc. Antacid tablets and processes for their preparation
US4180485A (en) * 1977-11-02 1979-12-25 The Procter & Gamble Company Spray-dried detergent compositions
CH636123A5 (de) * 1978-06-07 1983-05-13 Ciba Geigy Ag Verfahren zur herstellung schaumregulierter waschmittel.
US4386106A (en) * 1981-12-01 1983-05-31 Borden, Inc. Process for preparing a time delayed release flavorant and an improved flavored chewing gum composition
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4698264A (en) * 1982-08-02 1987-10-06 Durkee Industrial Foods, Corp. Particulate composition and process for making same
US4514319A (en) * 1983-03-25 1985-04-30 Union Carbide Corporation Antifoam composition containing hydrocarbon-silicon copolymer, hydrophobic filler and hydrocarbon oil
US4497832A (en) * 1983-04-18 1985-02-05 Warner-Lambert Company Chewing gum composition having enhanced flavor-sweetness
JPS59222209A (ja) * 1983-05-30 1984-12-13 Shin Etsu Chem Co Ltd 固形消泡剤
US4581381A (en) * 1983-11-14 1986-04-08 Nabisco Brands, Inc. Soft homogeneous antacid tablet
JPS6142309A (ja) * 1984-08-06 1986-02-28 Shin Etsu Chem Co Ltd 粉末消泡剤
US4590075A (en) * 1984-08-27 1986-05-20 Warner-Lambert Company Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8521956D0 (en) * 1985-09-04 1985-10-09 Unilever Plc Antifoam ingredient
US5004595A (en) * 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US4804543A (en) * 1987-07-14 1989-02-14 Warner-Lambert Company Novel hydrophilic plasticizing system and chewing gum containing same
US5024937A (en) * 1989-04-06 1991-06-18 Dow Corning Corporation Method for processing aqueous fermentation broths

Also Published As

Publication number Publication date
EP0425450B1 (fr) 1995-07-19
DE69021007D1 (de) 1995-08-24
JPH0815521B2 (ja) 1996-02-21
DE69021007T2 (de) 1996-03-21
EP0425450A3 (fr) 1991-07-10
CA2026030C (fr) 1997-04-01
US5073384A (en) 1991-12-17
JPH03151005A (ja) 1991-06-27
ATE125170T1 (de) 1995-08-15
EP0425450A2 (fr) 1991-05-02

Similar Documents

Publication Publication Date Title
EP0425450A3 (fr) Composition antimousse à base de maltodextrine
CA2101779A1 (fr) Composition de demoussage
MXPA99009542A (fr)
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
CA2395331A1 (fr) Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
ES2159524T3 (es) Preparacion farmaceutica para administrarse en el interior de las vias respiratorias.
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
CA2061917A1 (fr) Forme posologique effervescente pour enfants
ES8800039A1 (es) Un procedimiento para la preparacion de una composicion farmaceutica en polvo a base de silice o un silicato poroso.
CA2182508A1 (fr) Comprimes a l'epreuve d'un usage abusif
GR3017161T3 (en) Multi-fractionable tablet structure.
ATE271387T1 (de) Arzneizubereitungen enthaltend vitamin d und kalzium,ihre herstellung und therapeutische verwendung
DE60019239D1 (de) Fettlösliche Vitamine enthaltende Zusammensetzungen
DK0456720T3 (da) Granuleringer med højt ibuprofenindhold
AU6303690A (en) Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
CA2046533A1 (fr) Traitement de l'endometriose
SE8400723D0 (sv) Farmaceutisk komposition
AU6839890A (en) Pharmaceutical preparation for oral administration in fluid form
IE790194L (en) Pharmaceutical formulation
DE69414622D1 (de) Streptogramine in gereinigte Form, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
KR870010082A (ko) 구아르(guar) 분말
MY101916A (en) Etoposide oral dosage form.
IL113816A0 (en) Pharmaceutical compositions containing desogestrel their preparation and use
KR960705562A (ko) 입상 제제(Glanular preparation)

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed